Bringing you the latest cutting-edge research and commentary in bioscience.

Cell & Gene Therapy Insights

Cell & Gene Therapy Insights

Author Guidelines

Submit your work online or directly to our editorial office

A member of our editorial team will respond to you within 24 hours with an initial decision regarding your paper.

Submit Your Work

Download our Author Guidelines

Download PDF

BioInsights publishes high-quality research and commentary in cutting-edge areas of bioscience. We take the unique position of ensuring our publications help bridge the translational gap – publishing content relevant to all stakeholders and focusing on how advances in basic research can translate into new therapies.

Please see individual Journal Aims and Scope for journal-specific article types, but the below provides an overview of the content types published in BioInsights’ journals:

Our audience is the global scientific community within academia, industry and the healthcare community, as well as Investors/VCs, educators, policy makers and patient advocacy groups.


Formatting Guidelines

Author Names and Affiliations

Please include the full name, address, email, phone and fax numbers for all authors. Please designate one corresponding author. It is the corresponding author’s responsibility to ensure that the author list, and the summary of the author contributions to the study are accurate and complete.


The title should be concise – no more than 120 characters – and provide a clear understanding of the main topic being discussed.

Key Words

Please include 5-10 key words representative of the key topics discussed in your article.


The abstract succinctly introduces the paper and provides the reader with an overview of the key information discussed in your article. Your abstract should not be more than 150 words and must not include references.

Body of the Article

We do not impose strict word count restrictions, but please see the specific article type guidelines below for more specific formatting requirements.


BioInsights follows the reference style outlined in the ICMJE which can be summarised as follows:

References are listed and numbered in the order that they appear in the text
References should appear as a number within square brackets i.e., [1,2]

Any references that solely appear in tables/figures/boxes, should be included in the references section and appear based on the order in which they appear in the text.

Quote the first six author’s names in the reference; where there are more than six authors, please list the first three authors’ names followed by et al.

Only published or accepted manuscripts should be included in the reference list. Papers that have been submitted but not yet accepted should not be cited. All “personal communications” citations should be supported by a letter from the relevant authors and not included in the reference list.


Frock RL, Hu J, Meyers RM, Ho Y-J, Kii E & Alt FW. Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases. Nat. Biotechnol. 2015; 179-186.

Figures and Tables
We encourage authors to include figures, tables and boxes within the article body to aid the reader’s understanding. Please include a Figure/Table Legend to be included with your figures/tables. Any information that augments an article and could be viewed as stand-alone, should be included as a box.

At BioInsights, we provide our authors with exemplary support when compiling their article and in particular our design team are on hand to work with you to create any illustrations you may wish to add to your paper.

If any figures or tables used in your article require permission from the original publisher, it is the author’s responsibility to obtain this.


Article Types

Review Articles

Reviews highlight recent significant advances in a research area, providing readers with an up-to-date overview of the advances, challenges and predictions for future developments.

We also challenge our authors to provide their thoughts on the path to successful translation and development of therapies within the topic they have reviewed. The Translation Insight section gives the author the opportunity to provide their expert insight into how they envisage the field progressing towards commercially viable therapies – identifying challenges, research requirements, manufacturing needs, regulatory framework, and/or next steps required to move the field forward.

Required Article Structure:

Research Article/Original Research

Original research articles must present novel information that represents an advancement within the field. BioInsights accepts Research Articles, Preliminary Communications, Case Studies and Methodology papers under the Original Research category.

Required Article Structure:

Clinical Trial Reports

Clinical Trial Reports provide a detailed overview of ongoing or completed clinical trials. The articles are structured to provide the reader with a clear understanding of the clinical trial protocol, methodology, patient enrolment and selection, outcomes and their expert perspective on the implications of the trial data. For more detailed guidelines please contact

Technology/Therapy Insight

BioInsights publishes articles dedicated to reviewing a specific drug, therapeutic or technology/platform. For more detailed guidelines please contact

Commentary/Opinion Articles

Commentary articles provide authors with the opportunity to speculate and address any issues of contention or debate within the subject area of the journal. We encourage authors to be as opinionated as they wish as it is the intention that Commentary articles represent a personal perspective and help foster debate and discussion around key areas of bioscience.

Required Article Structure


Editorials are short commentary articles on a current topic of importance to the field and provides authors with the opportunity to convey their opinions on new developments or issues of debate.

Required Article Structure

Conference Insight

BioInsights recognises the value of conferences and aims to present the key highlights and information from recent conferences in bioscience with our Conference Insight articles.

Required Article Structure


Submission Guidelines

How to Submit your Work

Simply email a copy of your manuscript, with a cover letter/email directly to our Editorial Office, who are on hand to respond to you within 24 hours: editorial@ or you can submit your file online at here.

File Format

Your article should be submitted as one of the following:

Image files should be in high resolution:

Submitted image files should not be manipulated or adjusted in any way that could lead to misinterpretation of the information present in the original image.


Editorial Policies

Author Disclosure & Conflict of Interest Policies

Disclosure Forms can be downloaded here and must be complete by all authors.

Authors must state explicitly whether potential conflicts do or do not exist (e.g. personal or financial relationships that could influence their actions) and any such potential conflict of interest (including sources of funding) should be summarized in a separate section of the published article. Authors must disclose whether they have received writing assistance and identify the sources of funding for such assistance. Authors declaring no conflict of interest are required to publish a statement to that effect within the article.

Authors must certify that all affiliations with or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in their manuscript have been disclosed. Please note that examples of financial involvement include: employment, consultancies, honoraria, stock ownership or options, expert testimony, grants orpatents received or pending and royalties. This is list is not exclusive of other forms of financial involvement. Details of relevant conflicts of interests (or the lack of) must be declared in the ‘Disclosure’ section of the manuscript for all listed authors.

External peer reviewers must disclose any conflicts of interest that could bias their opinions of the manuscript, and they should disqualify themselves from reviewing specific manuscripts if they believe it appropriate. Should any such conflict of interest be declared, the journal editor will judge whether the reviewer’s comments should be recognized or will interpret the reviewer’s comments in the context of any such declaration.

Ethical Conduct of Research

Where articles include publication of original data relating to human or animal experimental investigations, appropriate institutional review board approval is required and should be described within the article. For those investigators who do not have formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed. For investigations involving human subjects, authors should explain how informed consent was obtained from the participants involved.

Patients’ Rights to Privacy

Patients have a right to privacy that should not be infringed without informed consent. Identifying information should not be included unless the information is essential for scientific purposes and the patient (or parent or legal guardian) gives written informed consent for publication. Informed consent for this purpose requires that the patient be shown the manuscript to be published. When informed consent has been obtained it should be indicated in the manuscript. In attempting to maintain patient anonymity, identifying details should be omitted where they are not essential. However, patient data should never be amended or falsified. Informed consent should be obtained whenever there is any doubt that anonymity can be assured.


Intentional plagiarism is unacceptable and any papers found to contain significant sections of plagiarised content will be rejected.


Open Access

BioInsights publishes a number of journals under an Open Access model. Open Access is a maturing business model within publishing and challenges the conventional subscription-based model. Rather than having your article behind a subscription pay wall, the open access model enables BioInsights to publish your work online and freely available for anyone to read and download.

To support the open access model and offset the expenses incurred with processing your article – including peer-review management, copyediting, production, graphics and design, online hosting – BioInsights charge a Publication Fee of £1,500, payable upon acceptance of your paper. Your article will be granted a CC-BY-NC-ND Open Access license. (Please see here for more information on creative commons licenses).

Under the CC-BY-NC-ND license, use of Open Access articles for commercial purposes is not permitted.

Commercial Purposes Include

For parties interested in using BioInsights content for commercial purposes please contact our editorial department

National Institutes of Health public access policy

Effective April 7, 2008, the National Institutes of Health (NIH) has stated that it will “require that all investigators funded by the NIH submit, or have submitted for them to the National Library of Medicine’s PubMed Central an electronic version of their final peer-reviewed manuscripts upon acceptance for publication, to be made publicly available no later than 12 months after the official date of publication…”

To assist our NIH-supported authors in meeting these requirements, BioInsights will submit the final published PDF to the NIH submission system on their behalf, within two weeks of online publication. Authors will then be asked to indicate the funding source as part of the submission process and the identified manuscripts will be transmitted to PubMed Central. The article will appear within PubMed’s index and be freely accessible no later than 12 months after publication.

Wellcome Trust open access policy compliance

In order to comply with Wellcome Trust policy for open access, Wellcome Trustfunded authors are able to opt for our Open Access Option, whereby in return for payment of an article processing fee and signing our Open Access agreement, we will make their article freely available to subscribers and non-subscribers on our website, and arrange for the final published version to be deposited into PubMed Central and UK PubMed Central on publication of their article, providing the Open Access payment has been received. Third parties will be entitled to re-use the Article, in whole or in part, in accordance with the conditions outlined in the Creative Commons Deed, Attribution 3.0 (CC-BY).

Twitter IconVisit Our Blog